CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset

Citations Over TimeTop 1% of 2019 papers

Abstract

Variable, glutamine-encoding, CAA interruptions indicate that a property of the uninterrupted HTT CAG repeat sequence, distinct from the length of huntingtin's polyglutamine segment, dictates the rate at which Huntington's disease (HD) develops. The timing of onset shows no significant association with HTT cis-eQTLs but is influenced, sometimes in a sex-specific manner, by polymorphic variation at multiple DNA maintenance genes, suggesting that the special onset-determining property of the uninterrupted CAG repeat is a propensity for length instability that leads to its somatic expansion. Additional naturally occurring genetic modifier loci, defined by GWAS, may influence HD pathogenesis through other mechanisms. These findings have profound implications for the pathogenesis of HD and other repeat diseases and question the fundamental premise that polyglutamine length determines the rate of pathogenesis in the "polyglutamine disorders."

Related Papers

• → Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease(2018)123 cited
• → Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington’s disease(2007)112 cited
• → Impaired mitochondrial trafficking in Huntington's disease(2009)67 cited
• → The calpain-suppressing effects of olesoxime in Huntington's disease(2016)15 cited
• → Recent Trends in Detection of Huntingtin and Preclinical Models of Huntington’s Disease(2014)5 cited